Psychiatry and Neurology, Neurology · Owosso, MI
NPI
1467771311
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
819 N Shiawassee St Ste 110
Owosso, MI, 48867
Phone (989) 723-1390
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
271 services
Medicare patients, 2024
128
Average age 62
Drug cost, 2024
$4.0M
3,415 prescriptions
Company payments, 2025
$252K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeanie L Cote was code 99214 (office e&m - established), 91 times for 66 patients. In total Jeanie L Cote billed 271 services in 18 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 91 | 66 | $60.25 | $5,483 |
| 99215 Office E&M - Established | Facility | 72 | 43 | $97.64 | $7,030 |
| 99215 Office E&M - Established | Office | 18 | 14 | $53.12 | $956 |
| 99214 Office E&M - Established | Office | 15 | 11 | $36.62 | $549 |
By year: 2022 $17K for 424 services; 2023 $19K for 297 services; 2024 $19K for 271 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeanie L Cote prescribed most often to Medicare patients was Gabapentin, with 280 prescriptions and refills. In total Jeanie L Cote wrote 3,415 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 280 | 470 | 66 | $5,477 |
| Baclofen Generic | 277 | 505 | 67 | $8,145 |
| Dalfampridine Er Dalfampridine | 210 | 272 | 36 | $85K |
| Pregabalin Generic | 168 | 222 | 35 | $2,776 |
| Tizanidine Hcl Generic | 150 | 202 | 34 | $3,169 |
| Kesimpta Pen Ofatumumab | 136 | 145 | 17 | $1.2M |
| Duloxetine Hcl Generic | 123 | 197 | 26 | $3,926 |
| Nortriptyline Hcl Generic | 118 | 149 | 24 | $1,191 |
| Teriflunomide Generic | 104 | 108 | 12 | $78K |
| Myrbetriq Mirabegron | 80 | 94 | 13 | $41K |
| Diazepam Generic | 78 | 107 | 28 | $374 |
| Levetiracetam Generic | 78 | 149 | 18 | $2,813 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 68 | 74 | 12 | $1,245 |
| Carbamazepine Generic | 59 | 77 | 11 | $2,761 |
| Modafinil Generic | 59 | 115 | 19 | $4,274 |
Brand drugs: 601 claims; generic drugs: 2,814 claims; opioid claims: 65.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeanie L Cote $252K ($249K in general payments such as food, travel and fees and $2,493 for research) from 28 companies. The largest payer was EMD Serono, Inc. with $139K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 114 | $139K |
| TG Therapeutics, Inc. TGTX | 38 | $34K |
| Biogen, Inc. BIIB | 33 | $29K |
| Ares Trading SA | 4 | $24K |
| Genentech USA, Inc. ROG.SW | 9 | $12K |
| Novartis Pharmaceuticals Corporation NVS | 19 | $5,465 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $5,388 |
| F. Hoffmann-La Roche AG ROG.SW | 1 | $2,493 |
| Abbvie Inc. ABBV | 36 | $449 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $175 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.